Clinical Profile of Attention Deficit Hyperactivity Disorder: Impact of Ethnic and Social Diversities in Israel
- PMID: 27468523
Clinical Profile of Attention Deficit Hyperactivity Disorder: Impact of Ethnic and Social Diversities in Israel
Abstract
Background: Despite the increased worldwide recognition of attention deficit/hyperactivity disorder (ADHD), there is a variability in the diagnostic rate of both ADHD and its co-morbidities. These diversities are probably related to the methodology and instruments used for the diagnosis of ADHD and to awareness and cultural interpretation of its existence.
Objectives: To identify consistent differences in the clinical profile of Arab and Jewish children with ADHD in Israel who differ in cultural, ethnic and socioeconomic background.
Methods: We analyzed the data of 823 children and adolescents with ADHD (516 Jews and 307 Arabs) and compared the clinical characteristics between these two ethnic groups. All patients were evaluated in two neuropediatric and child development centers in northern Israel: one in Haifa and one in Hadera. Children with autism and intellectual disabilities were excluded.
Results: The distribution of ADHD subtypes was similar in both populations. However, learning disorders and psychiatric co-morbidities (behavioral difficulties and anxiety) were reported more frequently in the Jewish population. The most commonly reported adverse effects to psychostimulants were mood changes, anorexia, headache, insomnia and rebound effect, and were more frequently reported in the Jewish population (42.0% vs.18.0%, P < 0.05).
Conclusions: We assume that these differences are related to cultural and socioeconomic factors. We suggest that the physician take cultural background into consideration when treating patients with ADHD.
Similar articles
-
The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.Isr Med Assoc J. 2014 Sep;16(9):568-73. Isr Med Assoc J. 2014. PMID: 25351015
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.Clin Neuropharmacol. 2011 Jul-Aug;34(4):148-54. doi: 10.1097/WNF.0b013e3182206dc1. Clin Neuropharmacol. 2011. PMID: 21738027
-
Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.J Clin Psychiatry. 1998;59 Suppl 7:50-8. J Clin Psychiatry. 1998. PMID: 9680053 Review.
-
Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.Child Adolesc Psychiatr Clin N Am. 2009 Oct;18(4):863-76. doi: 10.1016/j.chc.2009.04.011. Child Adolesc Psychiatr Clin N Am. 2009. PMID: 19836693 Review.
Cited by
-
Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD.Front Public Health. 2019 Jun 26;7:173. doi: 10.3389/fpubh.2019.00173. eCollection 2019. Front Public Health. 2019. PMID: 31294015 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical